Lv1
54 积分 2023-10-16 加入
Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer
7天前
已完结
Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations
7天前
已完结
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial
9天前
已完结
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma
10天前
已完结
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma
10天前
已完结
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
12天前
已完结
KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
2个月前
已完结
Membrane protein production and formulation for drug discovery
2个月前
已完结
Predicting the Impact of Drug Resistance Mutations on Inhibitor Potency with Molecular Dynamics and Machine Learning
3个月前
已完结
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
3个月前
已完结
皖公网安备34019202002308
